EGRX

Eagle Pharmaceuticals, Inc. EGRX

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode EGRX TRUFF MCUJF BLMH OILFF ECGS CNFHF UNVC VPHIF CLCFF
6M -88.17 % -16.46 % -12.00 % 12.52 % -8.13 % -58.43 % 9 900.00 % 8.00 % -99.79 % -10.00 %
YTD -21.43 % -44.17 % 39.50 % 57.78 % -11.80 % 91.59 % 0.00 % 26.17 % -99.79 % 66.67 %
1Y -43.10 % -37.96 % 27.69 % 54.35 % -16.00 % 127.78 % 0.00 % 8.00 % -99.79 % 54.64 %
3Y -98.87 % -70.94 % 0.73 % 3 450.00 % 20.16 % -8.38 % 0.00 % -71.28 % -99.97 % -61.43 %
5Y -99.30 % -92.92 % -0.60 % 373.33 % -69.16 % -88.92 % -99.91 % -84.02 % -99.99 % -94.60 %
10Y -99.64 % -92.92 % -71.86 % -47.41 % -82.36 % -88.92 % -99.91 % 2 600.00 % -99.99 % -94.25 %
From the beginning -97.43 % -92.92 % -96.54 % -95.88 % -82.36 % -88.92 % -99.91 % -99.97 % -99.99 % -94.25 %

Dividend